Introduction {#s1}
============

The ever-growing genome information has shed light on the expansion of the number of tRNA genes, which increases with the complexity of multicellular organisms ([@bib26]). Such an expansion of tRNA genes led to the appearance of tRNA isodecoders that is tRNAs ^*with*^ identical anticodon but with sequence variation(s) elsewhere. This sequence diversification has aided the functional expansion of the tRNA molecules from mere adapters in protein translation to versatile molecules involved in many non-canonical functions. Recent studies have shown the indispensable physiological roles of tRNA and tRNA-derived fragments in diverse functions, such as intergenerational inheritance, RNAi, gene regulation, apoptosis inhibition, ribosome biogenesis, stress granules and also in pathologies such as carcinoma ([@bib13]; [@bib23]; [@bib25]; [@bib33]; [@bib68]; [@bib71]; [@bib75]). The tRNA is abundantly saturated with identity elements which are essential for processing, structure, and also performing the canonical functions in translation. However, the emergence of tRNA isodecoders has led to the degeneracy of idiosyncratic features of a few tRNAs, which are essential for the canonical translation function ([@bib69]). Moreover, the advent of multicellularity has led to the production and use of reactive oxygen species (ROS) as signaling molecules, unlike bacteria and yeast that only respond to oxidative stress. It has been suggested that ROS adds the required diversity to the gamut of signaling events involved in cell differentiation and proliferation essential for multicellular systems such HIF pathway and signaling cascade by NRF-2, NFКB, Oct4, p53, etc ([@bib7]; [@bib8]; [@bib15]; [@bib43]; [@bib60]; [@bib74]; [@bib77]).

tRNA synthetases are essential enzymes responsible for maintaining fidelity during protein biosynthesis by selecting both the correct amino acid and tRNA ([@bib32]; [@bib62]). Alanyl-tRNA synthetase (AlaRS) is unique among this class of enzymes in using the universally conserved G3•U70 wobble base pair in the acceptor stem as an identity element for recognition and charging of tRNA^Ala^ ([@bib31]). Due to the phenomenon of a subtle recognition slippage, the archaeal and eukaryotic AlaRSs have a relaxed specificity for tRNA and can charge alanine on G4•U69 containing (non-cognate) tRNAs also ([@bib81]). Recently, we have shown that G4•U69 is predominant in kingdom Animalia, and specifically in tRNAs coding for Thr (18% in humans and sometimes as high as 43%, in *Takifugu rubripes*), thereby generating L-Ala-tRNA^Thr^(G4•U69) ([@bib40]). Such a tRNA misselection error can result in Thr-to-Ala mistranslation. However, the absence of Thr-to-Ala mutations at the proteome level indicated the presence of a dedicated proofreading factor ([@bib81]). We further showed that L-Ala-tRNA^Thr^(G4•U69) is robustly edited by Animalia-specific tRNA deacylase (ATD) in vitro ([@bib40]).

ATD is a paralog of a 'Chiral Proofreading' enzyme D-aminoacyl-tRNA deacylase (DTD), which is one of the key chiral checkpoints during protein synthesis and present across Bacteria and Eukarya ([@bib42]). Earlier studies using ligand-bound crystal structures, in combination with biochemical assays, have shown that DTD operates *via* L-chiral rejection mechanism and as a result also avoids mistranslation of L-Ala to achiral glycine ([@bib2]; [@bib41]; [@bib59]). The L-chiral rejection by DTD is attributed to an active site invariant cross-subunit *Gly-cisPro* motif that acts as a chiral-selectivity filter ([@bib67]). The Gly-Pro (GP) motif conformation has switched from *Gly-cisPro* in DTD to *Gly-transPro* in ATD. In Animalia, the appearance of tRNA^Thr^(G4•U69) is invariably correlated with the presence of ATD ([@bib40]). Thus, ATD is the first and the only known proofreader of tRNA misselection errors. However, the physiological significance and its role in translation quality control are not known. Given the emerging evidence of stress-induced regulation of mistranslation ([@bib55]; [@bib80]), the role of ATD in higher organisms is of immense interest. Here, we show that not only ATD but threonyl-tRNA synthetase (ThrRS) is also involved in correcting the tRNA-induced misselection error by AlaRS. As oxidative stress inhibits the proofreading activity of ThrRS, the protective activity of ATD is indispensable for avoiding mistranslation of Thr codons that is deleterious. Strikingly, the origin of ATD and the G4•U69 containing tRNAs are rooted in Choanoflagellates suggesting its importance for the origin of metazoans at the convergence of multicellularity-induced oxidative stress and tRNA isodecoder expansion.

Results {#s2}
=======

Absence of mistranslation in ATD knockout cells and its ubiquitous expression {#s2-1}
-----------------------------------------------------------------------------

Based on the earlier biochemical observations, ATD is expected to avoid Thr-to-Ala mistranslation, which would affect protein homeostasis and also cell survival. Hence to understand the physiological role and relevance of ATD, we generated a CRISPR-Cas9-based ATD knockout of HEK293T cells ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Surprisingly, the ATD null cells did not show any noticeable phenotypic effect which was puzzling, given that ATD is the only known editor of L-Ala-tRNA^Thr^(G4•U69). To further analyze the cells at the molecular levels, Hsp70 was chosen as the marker for proteome stress. Hsp70 is a chaperone which is upregulated in response to protein misfolding and hence used as a marker to study proteostasis stress, and is also implicated in aging and neurodegenerative diseases ([@bib27]; [@bib29]; [@bib53]; [@bib63]; [@bib70]). The ATD null cells also showed no significant difference in molecular proteome stress marker Hsp70 ([Figure 1B](#fig1){ref-type="fig"}). Lack of proteome errors is further confirmed by the identification of reporter protein peptides (explained later) using mass spectrometry experiments wherein no missubstitutions of alanine for threonine were observed. The above unexplainable results prompted us to check whether ATD is indeed expressed in vivo. The expression of ATD was initially checked in different cell lines (CHO, Neuro2A, SKOV3, HEK293T, HeLa, NIH/3T3, and mouse embryonic stem cells E14Tg2a), followed by different tissue samples of the mouse. We could see that ATD is ubiquitously expressed in all the cell lines and tissues of mouse tested thus underscoring its physiological importance ([Figure 1C,D](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). The expression data obtained is in line with the available databases such as Human protein Atlas (<https://www.proteinatlas.org/>), Zfin database (<https://zfin.org/>), Genecards (<https://www.genecards.org/>) and Bgee (<https://bgee.org/>). Despite the ubiquitous presence of ATD, the absence of any noticeable phenotypic and molecular changes in the ATD knockout cell lines prompted us to search for the presence of any other proofreading factor responsible for clearing L-Ala-tRNA^Thr^ in addition to ATD ([Figure 1E](#fig1){ref-type="fig"}).

![Unperturbed proteome homeostasis in *Atd* gene knockout cells and ubiquitous expression of ATD.\
(**A**) Western blot showing expression of ATD in wild type and ATD knockout cells of HEK293T. (**B**) Western blot of Hsp70 for checking protein misfolding in ATD knockout and wild type of HEK293T cells. No significant change was observed in Hsp70 levels of knockout and wild type. Expression of ATD in different tissues of mice from both (**C**) female and (**D**) male, using GAPDH as a loading control. The tissue samples of mice were lysed in RIPA buffer and quantified using Bradford colorimetric assay and an equal amount of protein was loaded (15 µg per well). (**E**) Schematic representing the tRNA misselection by AlaRS but no mistranslation in the ATD knockout cells indicating the presence of an unknown second proofreading factor for correcting L-Ala-tRNA^Thr^ error.](elife-58118-fig1){#fig1}

Cross-synthetase error correction in Animalia {#s2-2}
---------------------------------------------

The probable proofreading players in the cell that can deacylate L-Ala-tRNA^Thr^(G4•U69) and maintain the fidelity of translation in the absence of ATD include both *cis* (AlaRS, threonyl-tRNA synthetase (ThrRS)) and *trans* editors (AlaXp's and ProX) present in Animalia. Since L-Ala is a cognate amino acid for AlaRS and AlaXp's, the deacylation of L-Ala-tRNA^Thr^ by these editing domains is very unlikely [@bib6]; [@bib79]). ProX is specific to tRNA^Pro^ and its homolog (Ybak) is known to achieve substrate specificity by forming a binary complex with ProRS, which imparts tRNA specificity for editing ([@bib1]; [@bib3]; [@bib4]; [@bib14]). Thus, the only known and possible player with a high affinity for tRNA^Thr^ is ThrRS. ThrRS has an N-terminal editing domain, which is known to deacylate L-Ser erroneously charged on tRNA^Thr^ ([@bib17]). To test whether ThrRS indeed possess deacylation activity towards L-Ala-tRNA^Thr^, we incubated *M. musculus* ThrRS (MmThrRS) with the substrate. Intriguingly, MmThrRS was able to deacylate L-Ala-tRNA^Thr^ at 10 nM concentration but not L-Thr-tRNA^Thr^ ([Figure 2A,B](#fig2){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). This is the first identified instance where one aminoacyl-tRNA synthetase, ThrRS in this case, corrects the error caused by another aminoacyl-tRNA synthetase (AlaRS), which misselects the tRNA ([Figure 2C](#fig2){ref-type="fig"}). These results identified a two-tier functional redundancy in the cell for clearing L-Ala mistakenly attached to tRNA^Thr^ suggesting that ThrRS can correct the tRNA misselection error and hence compensate for the absence of ATD in the knockout cells that do not show any mistranslation of Thr-codons.

![Cross-synthetase error correction by ThrRS.\
(**A**) Deacylation of L-Ala-tRNA^Thr^(G4•U69) by MmThrRS and MmATD, the graph clearly shows that both the enzymes are active on the substrate. (**B**) Deacylation of L-Thr-tRNA^Thr^ by MmThrRS, and as expected MmThrRS has no activity on the cognate substrate. Data are represented as mean ± SD of at least three independent experiments. (**C**) Schematic showing the cross-synthetase error correction by ThrRS. ThrRS mischarges L-Ser on tRNA^Thr^ which is proofread by the editing domain of ThrRS. The tRNA induced misselection by AlaRS generates L-Ala-tRNA^Thr^(G4•U69), which is also proofread by ThrRS editing domain either from the free aminoacyl-tRNA pool or by resampling from EF-Tu.\
Figure 2---source data 1.Deacylation of L-Ala/Thr-tRNA^Thr^ by MmATD and MmThrRS.](elife-58118-fig2){#fig2}

###### Rate of deacylation by MmATD and MmThrRS.

Deacylation rates of L-Ala-tRNA^Thr^ (200 nM) by MmATD and MmThrRS. The *k*~obs~ values are calculated by fitting the deacylation curves ([Figures 2A](#fig2){ref-type="fig"} and [3F](#fig3){ref-type="fig"}) to the first-order exponential decay equation using GraphPad Prism.

  Enzymes   5 mM H~2~O~2~   \[Enzyme\]   *k*~obs~ (min^−1^)
  --------- --------------- ------------ --------------------
  ﻿MmATD    \-              1 nM         0.127 ± 0.004
  MmATD     \+              1 nM         0.152 ± 0.005
  MmThrRS   \-              10 nM        0.142 ± 0.004
  MmThrRS   \+              10 nM        No activity

L-Ala-tRNA^Thr^ activity of ThrRS is universally conserved {#s2-3}
----------------------------------------------------------

To validate the universality of the cross-synthetase error correction mechanism, we checked the activity of *D. rerio* (Dr) and *H. sapiens* (Hs) ThrRS on L-Ala-tRNA^Thr^ ([Figure 3A](#fig3){ref-type="fig"}). In line with the MmThrRS activity, DrThrRS and HsThrRS also deacylated L-Ala-tRNA^Thr^ robustly, indicating that the activity is conserved across higher eukaryotes. Therefore, in Animalia there exists a functional redundancy in clearing L-Ala-tRNA^Thr^ in the form of ATD and ThrRS ([Figure 2C](#fig2){ref-type="fig"}). It was tempting to check whether the L-Ala activity of ThrRS is conserved across different domains of life or has it been acquired over the course of evolution only in Animalia? It is worth noting here that it is only in Animalia that the error inducing tRNA species is present and hence the problem of L-Ala mischarging on tRNA^Thr^. To test this, we checked the deacylation activity of ThrRS from Bacteria. We were surprised to see that bacterial ThrRS from *E. coli* (EcThrRS) was active on L-Ala-tRNA^Thr^, even though neither Bacteria (bacterial AlaRS is discriminatory and charges only tRNAs containing G3•U70 \[[@bib81]\]) nor lower eukaryotes (which lack tRNAs containing G4•U69) possess the problem of tRNA misselection ([Figure 3---figure supplement 1A--C](#fig3s1){ref-type="fig"}). Therefore, it is perplexing as to why the L-Ala editing activity of ThrRS is universally conserved. In any case, these biochemical results clearly suggest that the editing site of ThrRS can accommodate and deacylate L-Ala mischarged on tRNA^Thr^, despite lacking the critical interactions emanating from the side chain hydroxyl group of serine ([Figure 3D,E](#fig3){ref-type="fig"}). Thus, in Animalia, ThrRS maintains the fidelity of decoding Thr codons by performing the dual function of clearing both amino acid (L-Ser-tRNA^Thr^) and tRNA misselection (L-Ala-tRNA^Thr^) errors ([Figure 3A--C](#fig3){ref-type="fig"}).

![ThrRS is sensitive to oxidative stress.\
(**A--C**) Deacylation of L-Ala/Ser/Thr-tRNA^Thr^ by ThrRS from different organisms in the absence of H~2~O~2~. (**D**) The active site of ThrRS editing domain in complex with L-Ser3AA (magenta sticks) showing the important interaction of the ligand with protein residues (PDB id: 1TKY). The amino acid (carbonyl oxygen and side chain hydroxyl group of L-Ser) of the incoming substrate is captured by an invariant Gly95 and His73. The ROS sensitive Cys182 (indicated using a yellow arrow) interacts with 2'OH of the terminal adenosine A76 of the aa-tRNA. (**E**) Structure-based sequence alignment of the ThrRS editing domain from different organisms, highlighting the invariance of residues His73, Gly95 and Cys182 throughout evolution from bacteria to humans, which are essential for the interaction with the substrate and catalysis. (**F**) Deacylation assay of L-Ala-tRNA^Thr^(G4•U69) by MmThrRS and MmATD in presence of 5 mM H~2~O~2~ in the reaction mixture. The graph clearly indicates that MmThrRS is inactive in the presence of H~2~O~2~ while ATDs activity is unaffected. (**G--I**) Deacylation of L-Ala/Ser/Thr-tRNAThr by ThrRS from different organisms in the presence of 5 mM H~2~O~2~. The biochemical data are represented by the mean ± SD of at least three independent experiments. (**J**) Schematic showing the functional redundancy of ThrRS and ATD in proofreading L-Ala-tRNA^Thr^(G4•U69) in reducing conditions, and inactivation of ThrRS during oxidative stress.\
Figure 3---source data 1.Deacylation of L-Ala/Thr/Ser-tRNA^Thr^ by ATD and ThrRS in presence and absence of oxidative stress.](elife-58118-fig3){#fig3}

ThrRS editing, but not aminoacylation, function gets inactivated during oxidative stress {#s2-4}
----------------------------------------------------------------------------------------

Recruitment of a new factor, ATD, even in the presence of ThrRS, a housekeeping gene, suggests the importance of avoiding Thr-to-Ala mistranslation. It raises an important question as to whether this functional redundancy is important for maintaining cellular protein homeostasis during any kind of physiological or stress conditions. Recent thiome studies using HeLa cell lysates show that ThrRS is oxidized at physiological conditions ([@bib47]) and the site of oxidation was found to be an active site invariant cysteine (C182) of ThrRS editing domain, which plays a crucial role in catalysis ([Figure 3D,E](#fig3){ref-type="fig"}). Oxidation of C182 abolishes the L-Ser-tRNA^Thr^ editing activity of *E. coli* ThrRS has been noted earlier ([@bib49]). We could establish that oxidizing conditions (using H~2~O~2~) do not affect the aminoacylation activity but results in a complete loss of L-Ala-tRNA^Thr^ and L-Ser-tRNA^Thr^ editing activity of MmThrRS ([Figure 3F](#fig3){ref-type="fig"}; [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Interestingly, the synthetase activity of MmThrRS is not affected even in the presence of 10-fold excess (50 mM) of H~2~O~2~. To establish the universality of oxidation-induced inactivation of ThrRS editing activity, we tested EcThrRS, DrThrRS, MmThrRS, and HsThrRS ([Figure 3F--I](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1D--F](#fig3s1){ref-type="fig"}). Irrespective of the organism (from bacteria to mammals), in the presence of oxidizing conditions the editing domain of ThrRS is inactive on L-Ala-tRNA^Thr^, however, this did not affect the aminoacylation activity of the enzyme. These deacylation experiments clearly show that the editing site cysteine is prone to oxidation and this feature is conserved across Bacteria and Eukarya.

ATD is inert towards oxidative stress {#s2-5}
-------------------------------------

Since ThrRS is inactive in the presence of ROS, the obvious question is whether ATD is active in the presence of oxidizing conditions? To this end, we checked for MmATD's activity on L-Ala-tRNA^Thr^ in the presence and absence of H~2~O~2~ and found that it was totally unaffected ([Figure 3F](#fig3){ref-type="fig"}). The inertness of ATD towards oxidative stress was further validated by performing L-Ala-tRNA^Thr^ deacylation assays using ATDs from different organisms such as *Hydra vulgaris* (HvATD) from the invertebrate Animalia, *Danio rerio* (DrATD) from class Pisces, *Gallus gallus* (GgATD) which belongs to Aves and *Homo sapiens* (HsATD) which is a mammal. Irrespective of the origin/class of organisms, all the ATDs were robust in deacylating L-Ala-tRNA^Thr^ even in the presence of oxidizing conditions (H~2~O~2~) ([Figure 3J](#fig3){ref-type="fig"}; [Figure 3---figure supplement 3A,B](#fig3s3){ref-type="fig"}). Hence, unlike ThrRS, ATD is insensitive to a significant amount of H~2~O~2~. This is in accordance with the absence of any cysteine residue in the active site of ATD, unlike that of ThrRS editing site ([Figure 3---figure supplement 4A,B](#fig3s4){ref-type="fig"}).

ROS induced cellular toxicity in ATD knockout cells {#s2-6}
---------------------------------------------------

We then asked if ATDs activity is not affected by H~2~O~2~, would this factor avoid Thr-to-Ala mistranslation during oxidative stress in vivo? To see the cellular effect and the essentiality of ATD, we initially treated the HEK293T wild type and ATD knockout cells with different concentrations of H~2~O~2~ (50, 75 and 100 µM) for 24 hr, followed by cell viability assay (MTT), which revealed that ATD knockout cells show pronounced cell death ([Figure 4A](#fig4){ref-type="fig"}; [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). We could further show that this is a direct effect of ATD by rescuing the cells from H~2~O~2~ induced toxicity by expressing FLAG-tagged ATD from a plasmid copy ([Figure 4B,C](#fig4){ref-type="fig"}). To further confirm that the rescue is due to the enzymatic activity of ATD, we used an enzymatically inactive G115F mutant of ATD. This mutant was generated based on our earlier studies on DTD's ligand-bound structures wherein an analogous mutation A112F (PfDTD, PDB id: 4NBI) sterically excludes the binding of adenine (A76) of the incoming substrate (aa-tRNA) and hence renders it inactive ([@bib2]). As expected, we could show that the G115F mutant of ATD also is similarly inactive for deacylation activity even with 1000-fold excess concentrations ([Figure 4D](#fig4){ref-type="fig"}; [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). The G115F mutant of ATD does not rescue ATD knockout cells from the oxidative stress-induced toxicity and therefore unequivocally establishes that it is ATDs enzymatic activity which is essential for the rescue during oxidative stress ([Figure 4B,C](#fig4){ref-type="fig"}).

![ATD is essential during oxidative stress.\
(**A**) Cell viability assay using MTT assay. Both wild type and knockout cells (knockout 1 and knockout 2 are two lines created using CRISPR-Cas9) are treated with varying concentrations of H~2~O~2~ followed by 24 hr of incubation and assessed for viability. The p-value is a comparison between the wild type and knockout at the same concentration of H~2~O~2~. (**B**) Overexpression of ATD rescues H~2~O~2~ induced cell toxicity: ATD knockout cells of HEK293T were transfected with a vector containing no insert, wild type ATD and inactive mutant of ATD, and treated with 75 µM H~2~O~2~ followed by MTT assay, all the values are normalized using H~2~O~2~-untreated cells as control. \* indicates p-value\<0.1 and \*\* indicates p-value\<0.01 obtained by doing student's t-test. (**C**) Immunoblotting of ATD knockout cells expressing FLAG-tagged ATD using Anti-ATD and Anti-FLAG antibody. (**D**) Deacylation of L-Ala-tRNA^Thr^ by G115F mutant of MmATD. Data points correspond to the mean of three independent readings and error bars represent one standard deviation. (**E--G**) Leishman-stained colonies of mouse ES cells after growing the wild type and ATD knockout cells in presence of 0.1X βME. (**H**) Graph representing the number of colonies formed by wild type E14Tg2a (mouse embryonic stem cells) and ATD knockout E14Tg2a cells (M-KO represents ATD knockout of MES cells, 1 and 2 refer to the clone number) formed when grown in media containing 0.1X βME compared to that of 1X βME (100 µM). (**I**) Probing for the markers of protein mistranslation, Hsp70, after exposing the wild type and ATD knockout cells to oxidative stress (75 µM of H~2~O~2~) for 6 hr. (p-value for untreated wild type and knockout is insignificant (ns) and the p-value between H~2~O~2~-treated wild type and control is 0.023, denoted by \*\* obtained by doing student's t-test).\
Figure 4---source data 1.Deacylation of L-Ala-tRNA^Thr^ by G115F mutant of ATD.](elife-58118-fig4){#fig4}

To further validate the in vivo results of HEK293T cells, we generated ATD knockout in mouse embryonic stem (mES) cells using the CRISPR-Cas9 paired guide strategy ([Figure 4---figure supplement 3A,B](#fig4s3){ref-type="fig"}). mES cells are known to have higher internal ROS and can be cultured only in the presence of antioxidants such as β-mercaptoethanol, which is usually added to the culture media ([@bib16]; [@bib28]). We altered the culture conditions by simply decreasing the concentration of the reducing agent, β-mercaptoethanol (βME). mES cells colonies were initially stained using the Leishman stain method and counted under the microscope. Interestingly, in the usual concentration of β-mercaptoethanol (100 µM) the wild type and ATD knockout mES cells were growing normally without any significant change in proliferation and survival. However, at 0.1X (10 µM) concentration of βME, the number of colonies in the knockout cells (from two independently derived clones) was significantly lower compared to that of wild type (([Figure 4E--H](#fig4){ref-type="fig"}). While the wild type and knockout have suffered at 0.05X concentration βME and no colonies were observed in the plate ([Figure 4---figure supplement 3C](#fig4s3){ref-type="fig"}). These results in combination with HEK293T data unequivocally establish that ATD is essential during physiological conditions of high oxidative stress. It is worth noting here that oxidative stress in ATD^-/-^ cells mimic the scenario of a double knockout condition in which ATD is absent and the editing domain of ThrRS is inactivated. Hence, the hypersensitivity of ATD knockout towards oxidative stress is due to the absence of both the deacylators of L-Ala-tRNA^Thr^ and therefore is expected to result in the mistranslation of Thr codons.

Perturbation of protein homeostasis in ATD^-/-^ cells under oxidative stress {#s2-7}
----------------------------------------------------------------------------

To check for mistranslation, initially, we set out to look for markers of protein misfolding such as Hsp70. The level of Hsp70 in ATD knockout cells was significantly upregulated (\>2 fold) in response to oxidative stress, while the wild type cells showed a marginal upregulation ([Figure 4I](#fig4){ref-type="fig"}). The mistranslation of Thr codons would also affect the overall cellular proteome homeostasis. To visualize the disturbance in the cellular proteostasis, we used EGFP tagged FlucDM as the sensor of proteome stress ([@bib27]). FlucDM-EGFP aggregates in response to proteome stress and can be visualized either by microscopy or by quantifying its ratio of insoluble to the soluble fraction in the cell. H~2~O~2~-treated ATD knockout cells have more speckles of GFP (due to aggregation of FlucDM) and show a dose-dependent increase in oxidative stress, while the number of aggregates in wild type increases only marginally ([Figure 5A](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). These observations are further validated by quantifying the ratio of insoluble-to-soluble FlucDM-EGFP using western blots, which showed a marked two-fold increase compared to wild type ([Figure 5B](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}), which is in line with the already observed 1.5 to 2-fold increase in FLucDM insoluble-to-soluble fraction ratio during different stress (heat and proteasome inhibitor) conditions ([@bib27]; [@bib65]). As further evidence to signify the role of ATD in oxidative stress, we observe the upregulation of ATD expression in H~2~O~2~-treated wild-type cells ([Figure 5C](#fig5){ref-type="fig"}). Therefore, ATD is an important factor needed to maintain cellular proteostasis during oxidative stress.

![ATD avoids ROS-induced mistranslation.\
(**A**) Microscopic images showing the aggregation of FlucDM-EGFP in the presence and absence of oxidative stress, in wild type and ATD knockout cells. The blue color corresponds to the DAPI staining of the nucleus while green corresponds to the GFP speckles formed due to the aggregation of FlucDM in response to the proteome stress. The scale corresponds to 10 µm. (**B**) Western blot-based quantification of soluble and insoluble (aggregates) fraction of FlucDM-EGFP using anti-GFP antibody. There was no significant difference between untreated wild type and knockout cells, while the treated cells had a significant difference and has a p-value of 0.032 obtained by doing student's t-test indicated by \*\*. (**C**) Overexpression of ATD in response to oxidative stress. Western blot of wild type HEK293T cells lysates after treating the cells with H~2~O~2~ for 2 hr and probed for expression of ATD using specific antibody. There was significant difference in ATD levels between treated and untreated cells, the \* indicates a p-value of 0.023 and \*\* indicated p-value of 0.016 obtained by doing student's t-test. (**D--F**) Tandem mass spectrometry-based analysis of the reporter protein (overexpressed GFP) isolated from H~2~O~2~-treated ATD knockout cells showing the wild type and mutant (Thr-to-Ser/Ala) spectra of the mistranslated peptides of the reporter protein. (**G**) Deacylation of L-Ser-tRNA^Thr^ by various concentrations of MmATD. (**H**) Deacylation of L-Ser-tRNA^Thr^ by MmATD in the presence and absence of elongation factor Tu. Even 500 nM of MmATD does not deacylate L-Ser-tRNA^Thr^ in presence of elongation factor. This signifies that even though ATD clears L-Ser-tRNA^Thr ^in vitro conditions, in vivo ATD does not deacylate L-Ser-tRNA^Thr^. Biochemical data is mean of at least three independent reading and error bars represent one standard deviation. (**I**) Percentage of peptides with Thr-to-Ala/Ser peptides found compared to that of the wild type peptides. (**J**) Table listing the number of wild type and mutant peptides found in the mass spectrometry experiments and the row highlighted in red corresponds to Thr-to-Ala mutation which is highest in the H~2~O~2~-treated ATD knockout cells.\
Figure 5---source data 1.In vivo ATD edits L-Ala-tRNA^Thr^ but not L-Ser-tRNA^Thr^.](elife-58118-fig5){#fig5}

ATD is essential to avoid Thr-to-Ala substitution in Animalia {#s2-8}
-------------------------------------------------------------

The earlier observed proteome stress is very likely due to Thr codons\' mistranslation. To pinpoint the exact cause of proteome stress, we overexpressed a reporter protein (GFP using pEGFP vector) with and without oxidative stress, followed by GFP pull-down and subjected to peptide identification using mass spectrometry (MS/MS). The MS/MS data was examined for amino acid substitutions using a GFP-mutant database. We could read increased mistranslation of Thr-to-Ser in a few peptides of samples purified from H~2~O~2~-treated wild type cells ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). This quickly rules out the possibility of ATD proofreading L-Ser-tRNA^Thr^, which is in accordance with the low activity of ATD and its likely inability to resample from elongation factor thermo unstable (EF-Tu) ([Figure 5G,H](#fig5){ref-type="fig"}). However, no toxicity is observed in these cells since the mutation of Thr-to-Ser is a milder substitution and therefore tolerable. In the case of H~2~O~2~-treated ATD knockout cells, the level of Thr-to-Ser mistranslation is similar to that of wild type and further validates our biochemical data that ATD cannot proofread L-Ser-tRNA^Thr^ in vivo. Unlike Thr-to-Ser substitutions, the levels of Thr-to-Ala mistranslation was significantly higher in cells devoid of ATD and treated with H~2~O~2~ ([Figure 5D--F](#fig5){ref-type="fig"}). As expected, except for Ser and Ala, Thr codons were not mistranslated to other amino acids such as smaller Gly, and bigger Leu, Tyr, and Phe. Since Thr-to-Ala is a drastic change of size, shape, and polarity, it destabilizes the structural integrity of the proteome producing the observed toxicity to the cell. These findings unambiguously provide direct evidence that ATD and ThrRS can proofread L-Ala-tRNA^Thr ^in vivo and the former plays a critical role during oxidative stress.

Choanoflagellates represent the pre-metazoan ancestry of ATD {#s2-9}
------------------------------------------------------------

ATD is present in kingdom Animalia and so is tRNA^Thr^ possessing G4•U69. Since ATD is a paralog and evolved from a pre-existing DTD, we were curious to find out the first event of emergence or an intermediate of this transition. By extensive bioinformatics search, we have identified that ATD is present in *Salpingoeca rosetta -*a Choanoflagellate ([Figure 6A,B](#fig6){ref-type="fig"}), but not in other unicellular eukaryotes (like yeast, Plasmodium, Ichthyosporeans, and Filastereans). Choanoflagellates are the colonial unicellular cousins of multicellular animals, and recent studies have shown that these organisms possess genes that are unique to kingdom Animalia and essential for multicellularity i.e., cell cycle regulation (p53), adhesion molecules (cadherin's), hypoxia signaling pathway (prolyl hydroxylase), immune system, sexual reproduction, meiotic division, etc. ([Table 2](#table2){ref-type="table"}; [@bib9]; [@bib20]; [@bib37]; [@bib78]; [@bib84]). A thorough phylogenetic analysis of all the available ATD sequences has shown that the emergence of ATD is rooted in Choanoflagellates, which possesses ATD in addition to having a canonical DTD ([Figure 6A](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Intriguingly, Choanoflagellate ATD has mixed characteristics of both ATD and DTD. The two signature sequence motifs characteristic of all bacterial and eukaryotic DTD are SQFTL and NXGPXT, while PQATL and TNGPY/FTH typify ATD. Choanoflagellate ATD is unusual in having one motif each from ATD and DTD i.e., PQATL and NDGPFT respectively, thus capturing an intermediate in the transition and emergence of a paralog of DTD ([Figure 6A](#fig6){ref-type="fig"}). Using the available transcriptome and genomics data of different Choanoflagellates, we could identify ATD in a few more Choanoflagellates (*S. macrocollata, S. dolichothecata, S. helianthica, Codosiga hollandica, Mylnosiga fluctuans, and Choanoeca flexa*) ([@bib9]; [@bib66]) and all represent the transition state ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Based on the aforementioned mixed features, Choanoflagellate represents a unique case of an intermediate in the metamorphosis of DTD to ATD from the amino acid sequence perspective. We further wanted to check whether this ancestor of Animalia ATD would perform a similar proofreading function. Indeed, biochemical assays showed that *S. rosetta* ATD (SrATD) was active on L-Ala-tRNA^Thr^ thereby proving it to be a functional ATD and not DTD, which is a 'Chiral Proofreader' that does not act on L-aminoacyl-tRNA substrates ([@bib2]; [Figure 6C](#fig6){ref-type="fig"}). Interestingly, SrATD was not only active on L-Ala mischarged on non-cognate tRNA but also could discriminate the correctly charged substrates (L-Ala-tRNA^Ala^) ([Figure 6D](#fig6){ref-type="fig"}) by 10-fold. The discrimination potential between cognate and non-cognate will be further enhanced in the presence of Elongation factor which binds L-Ala-tRNA^Ala^ strongly compared to that of L-Ala-tRNA^Thr^ ([@bib40]; [@bib45]). These bioinformatic analysis in combination with biochemical assays provide the basis for the emergence of ATD in the ancestors/cousins of Animalia ([Figure 6B](#fig6){ref-type="fig"}).

![Choanoflagellates mark the origin of ATD and G4•U69 containing tRNA isodecoders.\
(**A**) Structure-based sequence alignment of ATD and DTD sequences across organisms with Choanoflagellate ATD marked in green, which has characteristic motifs from both ATD and DTD. The sequences clearly show the mixed features of Choanoflagellate ATD in having both NXGPXT (DTD-specific) and PQATL (ATD-specific) motif along with a DTD-specific Arg/Lys (Arg7 in *E. coli* DTD, marked with a green star). While lacking the ATD specific Arg151 (marked with a red star). (**B**) The evolutionary tree showing the ATD emergence of ATD in the common ancestors of Choanoflagellates and Animals while absent in other branches of life (except few pathogens such as *Leishmania, Trypanosomes, Acanthamoeba,* which might have acquired from the host genome). Deacylation of (**C**) L-Ala-tRNA^Thr^ and (**D**) L-Ala-tRNA^Ala^ by various concentrations of *S. rosetta* ATD. Biochemical graphs are plotted using mean values and error bars represent the standard deviation. (**E**) Correlation between cell types and number of tRNA genes: Dot plot showing the number of unique tRNA genes and cell types in organisms (taken from [@bib82]) across different life forms. The dotted orange line indicates the number of tRNAs in *S. rosetta* obtained using tRNA-Scan ([@bib12]) of the genome ([@bib21]). (**F**) Co-evolution of tRNA^Thr^(G4•U69) and ATD: The emergence of ATD is highly linked with the appearance of tRNA isodecoders containing G4•U69. ● indicates the presence of the gene, while ○ indicates absence. Choanoflagellates mark the beginning of both ATD and tRNA isodecoders with G4•U69. Intriguingly, the Choanoflagellate ATD is in a transition state and G4•U69 is present in tRNA^Gln^, and not in tRNA^Thr^, and hence indicated with grey circles.\
Figure 6---source data 1.Choanoflagellate ATD edits L-Ala-tRNA^Thr^.](elife-58118-fig6){#fig6}

###### ATD is one of the key genomic innovations that arose in Choanoflagellates which is important for multicellularity.

The symbol • (dot) indicates the presence of the gene, while a white box indicates the absence of the gene in that particular organism. In the case of Porifera and Nematoda which are marked with sky blue color fill, ATD is absent and the tRNA misselection inducing species tRNA^Thr^(G4•U69) is also absent. ATD and tRNA^Thr^(G4•U69) genes are absent in few Annelids and Arthropods hence the boxes are lightly shaded. The data for genes other than ATD are retrieved from [@bib37]; [@bib56]; [@bib66]; [@bib73].

  Process            Cell cycle regulation   HIF pathway   Immune response   Quality Control   
  ------------------ ----------------------- ------------- ----------------- ----------------- ---
  Phylum             Organism                                                                  
  Choanoflagellate   *S. rosetta*            ●             ●                 ●                 ●
  Porifera           *X. testudinaria*                                       ●                 ●
  Cnidaria           *H. vulgaris*           ●             ●                 ●                 ●
  Nematoda           *C. elegans*            ●             ●                                   ●
  Arthropda          *I. scapularis*         ●             ●                 ●                 ●
  Annelida           *C. teleta*             ●             ●                 ●                 ●
  Platyhelminthus    *S. mansoni*            ●             ●                 ●                 ●
  Mollusca           *O. vulgaris*           ●             ●                 ●                 ●
  Echinodermata      *S. purpuratus*         ●             ●                 ●                 ●
  Pisces             *D. rerio*              ●             ●                 ●                 ●
  Amphibia           *X. tropicalis*         ●             ●                 ●                 ●
  Aves               *G. gallus*             ●             ●                 ●                 ●
  Reptiles           *N. Naja*               ●             ●                 ●                 ●
  Mammals            *H. sapiens*            ●             ●                 ●                 ●
  Protein/Gene       p53                     PHD           NF-κB             ATD               

tRNA isodecoder containing G4•U69 also emerged in the unicellular ancestors of animals tRNA misselection by AlaRS is due to the appearance of tRNA isodecoders containing G4•U69 which is in turn linked to the expansion of tRNA genes. The number of unique tRNA genes is highly correlated to the complexity of the organisms (number of cell types) ([Figure 6E](#fig6){ref-type="fig"}). The presence of G4•U69 in tRNA^Thr^ can be traced from Cnidaria (*Hydra vulgaris*) to the recently evolved mammals (*Homo sapiens*) as is the case for ATD ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}). Interestingly, Choanoflagellates (*S. rosetta*) represent a stage of transition with 89 unique tRNAs, of which G4•U69 is seen in tRNA^Gln^ and tRNA^His^, but not in tRNA^Thr^ ([Figure 6---figure supplement 4](#fig6s4){ref-type="fig"}). Since in eukaryotes, tRNA^His^ undergoes a post-transcriptional modification of adding guanine at the −1 position, which acts as a major determinant for histidyl-tRNA synthetase and a negative determinant for rest of the synthetases, and therefore would make it inert towards AlaRS ([@bib24]; [@bib34]; [@bib83]). However, the presence of G4•U69 in tRNA^Gln^ possibly necessitates that Choanoflagellates have a proofreading factor that can edit L-Ala erroneously charged on tRNA^Gln^(G4•U69). We could show that tRNA^Gln^(G4•U69) could be charged by AlaRS albeit at much lower levels of 4% to 7% than observed for tRNA^Thr^(G4•U69) at 30% to 40% ([Figure 6---figure supplement 5](#fig6s5){ref-type="fig"}). Due to the low levels of aminoacylation of Choanoflagellate tRNA^Gln^(G4•U69), we could not perform the deacylation assays using L-Ala-tRNA^Gln^. In any case, even such low levels of tRNA misselection would be precarious and Choanoflagellate ATD, which is in transition, is expected to act on these substrates and this aspect requires further probing. Therefore, the presence of ATD strictly alongside tRNA isodecoders containing G4•U69 even in Choanoflagellates, but not in fungi or other protists, underscores that ATD's emergence is strongly linked with the appearance of tRNA isodecoders containing G4•U69 ([Figure 6F](#fig6){ref-type="fig"}).

Discussion {#s3}
==========

ROS is an inevitable cellular metabolite of increased metabolism in animals, produced by mitohormesis, NOX enzymes and also β-oxidation of lipids in peroxisomes ([@bib5]; [@bib44]; [@bib51]). Unlike bacteria and lower eukaryotes, in Animalia ROS is an important signaling molecule and implicated in many cellular pathways (activating NFκB, NRF2, p53, Oct4, etc.) and also for the origin of multicellularity ([@bib7]; [@bib8]; [@bib15]; [@bib43]; [@bib60]; [@bib74]; [@bib77]). Cells avoid or nullify the toxic effects of ROS on protein quality control either by improving the fidelity of aminoacyl-tRNA synthetase or by increasing the overall Met content in the cellular proteome ([@bib26]; [@bib49]). In the case of proofreading tRNA misselection, the functional redundancy of editing L-Ala-tRNA^Thr^ by ThrRS and ATD is broken in the presence of oxidative stress. As mentioned earlier, thiome studies have shown that Cys182 (residue number corresponds to *E. coli* ThrRS), which is essential for editing activity, gets oxidized at physiological conditions (cellular ROS). Since oxidative stress is an important component of multicellular systems, the innovation of ATD in Choanoflagellates seems to be essential to avoid the deleterious effects of tRNA misselection on the cellular proteome. Choanoflagellates mark the origin of many Animalia-specific genes which are essential for multicellularity ([@bib10]; [@bib9]; [@bib20]; [@bib66]; [@bib78]; [@bib85]). Therefore, the emergence of this metazoan specific proofreader, ATD, in Choanoflagellates is strictly linked to the appearance of tRNA isodecoders containing G4•U69 and underscoring a strong coevolution of these two, thus implicating their role in the emergence of multicellularity ([Figure 6E,F](#fig6){ref-type="fig"} and [Figure 7](#fig7){ref-type="fig"}).

![The confluence of tRNA isodecoder expansion and oxidative stress necessitates the recruitment of ATD in kingdom Animalia.\
(1) Genome expansion leads to the appearance of (2,3) tRNA isodecoders which are used in different canonical and non-canonical functions, of which tRNA^Thr^(G4•U69) is (4) mischarged by AlaRS, to give the tRNA misselection product L-Ala-tRNA^Thr^(G4•U69). (5) in vitro these misselection products are cleared by ThrRS and ATD. 6) In multicellular animals, ROS acts as an important cellular metabolite performing various physiological functions by triggering the appropriate signaling pathway. 7) ROS generated internally in cells oxidizes the active site cysteine of ThrRS editing domain thereby affecting its proofreading activity on L-Ala-tRNA^Thr^. 8) To avoid mistranslation ATD is recruited in Animals and Choanoflagellates as it is inert towards ROS and robustly proofreads L-Ala-tRNA^Thr^ to avoid (9) Thr-to-Ala mistranslation at the proteome level followed by cell death. 10) The tRNA isodecoders that are deacylated by ATD can either go for fresh aminoacylation or can be rerouted for other non-canonical functions.](elife-58118-fig7){#fig7}

Recent studies have demonstrated the versatile roles of tRNA and tRNA-derived fragments in multiple cellular functions such as regulation, sperm fertility, intergeneration inheritance, and integrated stress response ([@bib18]; [@bib22]; [@bib23]; [@bib54]; [@bib72]). The appearance of tRNA^Thr^ isodecoders with G4•U69 in Animalia, and its conservation at the cost of tRNA misselection suggests a strong physiological role. The presence of 3' tRNA-derived fragments (tRF id: 3020a and 3020b) of the tRNA^Thr^(G4•U69) in the tRF database (<http://genome.bioch.virginia.edu/trfdb/>) ([@bib38]) indicates the possible role of these isodecoders in non-canonical functions. One of the unknown puzzles in RNA biology is how these tRNAs are effectively routed for non-canonical functions. Post-transcriptional modifications of tRNA are implicated in regulating the tRNA folding and also fragments generation ([@bib19]; [@bib50]; [@bib58]). However, tRNAs once aminoacylated are channeled to the ribosome by elongation factor. Therefore, the presence of deacylators like ATD and ThrRS can strip the non-cognate amino acid from these tRNAs and thus provides one of the plausible ways of diverting a part of the tRNA pool away from translation ([Figure 7](#fig7){ref-type="fig"}). It appears that the emergence of ATD as a translational quality control factor in Choanoflagellates has been utilized to selectively regulate the free tRNA pool for other non-canonical functions in Animalia, which remains to be explored.

Similar to genetic variations allowing to adapt/provide an advantage in stress conditions, the generation of variations at the proteome levels are known to be advantageous ([@bib36]; [@bib52]). In lower systems such as *Mycoplasma*, mistranslation has been shown to be advantageous, wherein the presence of editing defective aaRSs (LeuRS, ThrRS, PheRS) allows the organism to gain phenotypic plasticity by generating proteome diversity ([@bib48]; [@bib52]; [@bib61]). The current work involves the use of acute oxidative stress (H~2~O~2~) and further prompts to look at the behavior of ATD knockout cells in the presence of chronic oxidative stress such as activators of NADPH oxidase. ROS-induced inactivation of the editing activity of ThrRS can be used as a conserved mechanism for generating subtle variations in the cellular proteome. At the same time, the spatiotemporal regulation of ATD in combination with oxidative stress can generate a huge repertoire of proteome diversity that can be beneficial under certain cellular scenarios. ATD\'s expression levels are very likely modulated by the level of oxidative stress as seen in the case of reproductive tissues ([Figure 1C,D](#fig1){ref-type="fig"}), which also suggests a mode of regulation via a feedback mechanism. It is worth noting here that the appearance of multicellular animals \~ 750 million years ago is also marked by a significant increase in the global atmospheric oxygen levels which moved from \<10% to nearly 20% ([@bib30]; [@bib39]). Overall, the confluence of tRNA expansion ([Figure 7](#fig7){ref-type="fig"}) and oxidative stress, both external and internal, necessitates the emergence of ATD to maintain cellular proteostasis in Animalia.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                Designation                            Source or\                                                      Identifiers                                                               Additional\
  (species) or\                                                       reference                                                                                                                                 information
  resource                                                                                                                                                                                                      
  ---------------------------- -------------------------------------- --------------------------------------------------------------- ------------------------------------------------------------------------- ------------------------------------------
  Strain, strain background\   BL21(DE3)                              GE Healthcare                                                   GE27-1542-01                                                              \-
  (*Escherichia coli*)                                                                                                                                                                                          

  Strain, strain background\   Rosetta(DE3)                           Sigma-Aldrich                                                   70954                                                                     \-
  (*Escherichia coli*)                                                                                                                                                                                          

  Cell line\                   HEK293T                                ATCC                                                            CRL-3216\                                                                 \-
  (*Homo sapiens*)                                                                                                                    (RRID:[CVCL_0063](https://scicrunch.org/resolver/CVCL_0063))              

  Cell line\                   E14Tg2a                                ATCC                                                            CRL-1821\                                                                 \-
  (*Mus musculus*)                                                                                                                    (RRID:[CVCL_9108](https://scicrunch.org/resolver/CVCL_9108))              

  Antibody                     Anti-ATD\                              Invitrogen                                                      PA524053\                                                                 1:2000
                               (Rabbit and polyclonal)                                                                                (RRID:[AB_2541553](https://scicrunch.org/resolver/AB_2541553))            

  Antibody                     Anti HSP-70 (Mouse and monoclonal)     Abcam                                                           ab47454\                                                                  1:5000
                                                                                                                                      (RRID:[AB_881521](https://scicrunch.org/resolver/AB_881521))              

  Antibody                     Anti-GFP\                              CST                                                             2956S\                                                                    1:5000
                               (Rabbit and monoclonal)                                                                                (RRID:[AB_1196615](https://scicrunch.org/resolver/AB_1196615))            

  Antibody                     Anti-GAPDH\                            Abcam                                                           ab8245\                                                                   1:2000
                               (mouse and Monoclonal)                                                                                 (RRID:[AB_2107448](https://scicrunch.org/resolver/AB_2107448))            

  Antibody                     Anti-β-actin (Rabbit and monoclonal)   Santacruz                                                       Sc47778\                                                                  1:2000
                                                                                                                                      (RRID:[AB_2714189](https://scicrunch.org/resolver/AB_2714189))            

  Antibody                     Anti-mouse IgG\                        GE Healthcare                                                   NA931-1ML\                                                                1:2000
                               (Rabbit and monoclonal)                                                                                (RRID:[AB_772210](https://scicrunch.org/resolver/AB_772210))              

  Antibody                     Anti-rabbit IgG\                       Santacruz                                                       sc-2357\                                                                  1:10000
                               (Mouse and monoclonal)                                                                                 (RRID:[AB_628497](https://scicrunch.org/resolver/AB_628497))              

  Recombinant DNA reagent      *Escherichia coli* ThrRS (Plasmid)     PMID:[26113036](https://www.ncbi.nlm.nih.gov/pubmed/26113036)   UniProt id: P0A8M3                                                        Cloned in pET28b\
                                                                                                                                                                                                                (N-terminal 6X-His tag)

  Recombinant DNA reagent      *Danio rerio* ThrRS (Plasmid)          This paper                                                      Uniprot id: A2BIM7                                                        Cloned in pET28b\
                                                                                                                                                                                                                (N-terminal 6X-His tag)

  Recombinant DNA reagent      *Homo sapiens* ThrRS (Plasmid)         This paper                                                      Uniprot id: P26639                                                        Cloned in pET28b\
                                                                                                                                                                                                                (N-terminal 6X-His tag)

  Recombinant DNA reagent      *Mus musculus* ThrRS (Plasmid)         PMID:[29579307](https://www.ncbi.nlm.nih.gov/pubmed/29579307)   \-                                                                        Cloned in pET28a\
                                                                                                                                                                                                                (N-terminal 6X-His tag)

  Recombinant DNA reagent      *Hydra vulgaris* ATD (Plasmid)         This paper                                                      \-                                                                        Cloned in pET28b\
                                                                                                                                                                                                                (C-terminal 6X-His tag)

  Recombinant DNA reagent      *Salpingoeca rosetta* ATD (Plasmid)    This paper                                                      \-                                                                        Cloned in pET28b\
                                                                                                                                                                                                                (C-terminal 6X-His tag)

  Recombinant DNA reagent      FlucDM-EGFP (Plasmid)                  PMID:[21892152](https://www.ncbi.nlm.nih.gov/pubmed/21892152)   \-                                                                        \-

  Recombinant DNA reagent      *Mus musculus* ATD (Plasmid)           This paper                                                      Uniprot id: Q8BHA3                                                        Cloned in pEGFP-N1 (C-terminal FLAG tag)

  Recombinant DNA reagent      *Mus musculus* ATD G115F (Plasmid)     This paper                                                      \-                                                                        Cloned in pEGFP-N1 (C-terminal FLAG tag)

  Commercial assay or kit      Lipofectamine 3000                     ThermoFisher Scientific                                         [L3000015](https://www.thermofisher.com/order/catalog/product/L3000015)   \-
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Biochemistry {#s4-1}
------------

All the components for biochemical assays were generated as mentioned in [@bib40]. The sequence coding for threonyl-tRNA synthetase (*Homo sapiens, Danio rerio,* and *Escherichia coli*) was amplified from cDNA for human and zebrafish and from genome for *E. coli* and cloned into pET28b with an N-terminal 6X His-tag. All the proteins were expressed in *E. coli* BL21-CodonPlus(DE3)-RIL strain, except *E. coli* ThrRS, which was expressed in *E. coli* BL21. All the proteins were purified using the affinity-based column (Ni-NTA), followed by size exclusion chromatography. Purified proteins were stored at −30°C in 150 mM NaCl, 200 mM Tris (pH 7.5) and 50% glycerol. Genes coding *M. musculus* tRNA^Thr^(G4•U69), tRNA^Ala^ is in vitro transcribed using MEGAshortscript T7 Transcription Kit (Thermo Fisher Scientific, USA), followed by 3' end labeling using CCA-adding enzyme ([@bib46]). Alanylation of tRNA^Thr^(G4•U69) was done using *M. musculus* alanyl-tRNA synthetase. EF-Tu activation experiments were performed using pyruvate kinase and phosphoenolpyruvate as explained in [@bib67]. Deacylations were performed using a range of enzyme concentrations, while the concentration which gave a gradual curve was used for curve fitting in GraphPad Prism software, and each data point in the graph represents mean of at least three reading, while the error bars represent the standard deviation from the mean.

Cell culture, transfection, and microscopy {#s4-2}
------------------------------------------

HEK293T cells were acquired from ATCC and confirmed using STR profiling. HEK293T cells were cultured and maintained in DMEM containing 10% fetal bovine serum, 50 IU ml^−1^ penicillin, and 50 μg ml^−1^ streptomycin. Cultures were grown in a humidified incubator at 37°C and 5% CO~2~. Transfections were done using Lipofectamine 3000 reagent (Invitrogen) according to the manufacturer's manual. A routine check for mycoplasma contamination was checked using DAPI staining. For microscopy the cells were grown on coverslips, fixed with 10% formaldehyde, permeabilized with Triton X100, and stained with DAPI (Sigma). The cells were imaged in Zeiss Axioimager Z.1 Microscope or Leica TCS SP8.

Mouse ES cells (E14Tg2a) were grown as described in [@bib35]. Briefly, cells were cultured on tissue culture-treated plates/dishes coated with 0.1% gelatine, in GMEM media supplemented with L- glutamine, 100 µM β-mercaptoethanol, 1 mM non-essential amino acids (Gibco), 100 units/ml human LIF supplemented with 10% fetal bovine serum (Gibco). Cultures were grown in a humidified incubator at 37°C and 5% CO~2~. mES cells were transfected using P3 Primary cell 4D-Nucleofector Kit. For colony formation assay of ES cells, 200 cells per well (6 well plate) were plated and Leishman staining was done after 5 days of growth, the cell were grown in media containing a variable concentration of β-mercaptoethanol.

Knockout generation {#s4-3}
-------------------

For generating knockout in HEK293T, two SgRNAs were designed to target the intron1 and exon1 region of the *Atd* gene, the sequences of the gRNA are sgRNA1-5' TTCGTCGTGCCCCGCCTCGTC 3' and SgRNA2-5' CAGATCGCGTCGAATTCCCC 3'. The SgRNA oligos were cloned into the BbsI sites of pU6-(BbsI)-CBh-Cas9-T2A-iRFP670 and verified by sequencing. The U6-SgRNA1-gRNA scaffold cassette was amplified and cloned into the XbaI site of the pU6-(BbsI)-CBh-Cas9-T2A-iRFP670 plasmid contains the sgRNA2 to generate a dual sgRNA plasmid. These dual SgRNA plasmids were transfected into HEK293T cells, followed by cell sorting to enrich for transfected cells expressing iRFP670. The sorted cells were cultured and clones were established by dilution cloning. The genomic DNA from replica plates of the clones were genotyped by PCR using primers flanking the sgRNAs regions to detect the deletion in ATD locus. The forward primer 5' CACTGAGCGCCTTCTACAGAGTTG 3' and reverse primer 5' GAAAGTAGAAGGAACTCATAGTGAC 3'. The ATD knockouts were further validated by sequencing the PCR amplicon and by performing western blot for ATD protein.

Sg RNA oligos for mouse ES cell knockouts were designed at the exon1 and intron1 junction of the gene coding for ATD, the sequences of the oligos are 5' GGCCGATGGAGACGCCGCGG 3' and 5' CCCTATCCGCGGAACCGTGC 3'. The protocol for knockout generation in ES cells is identical to HEK293T cells, except that the plasmid was transfected into the cells using nucleofection. The mES cell colonies were screened using gene-specific primers 5' CAAAGCTGGTCAATTCCACATCCG 3' and 5' ATTCTGAGAAGCGAGATGGCTCAC 3' which flank the target region.

MTT assay {#s4-4}
---------

The wild type and ATD knockout HEK293T cells were plated in 12 well culture plates (50000 cells/well) and incubated for 24 hr in CO~2~ incubator. The following day different concentrations of H~2~O~2~ (50, 75, and 100 µM) were added to the corresponding wells and incubated for 24 hr. After the incubation time, 0.5 mg/ml of MTT solution was added to each well and incubated in dark for 3 to 4 hr. The Formazan crystals were dissolved by adding 500 µl of 10% acidified-SDS, followed by transfer to 96 well plates. The intensity of the color was measured using a spectrophotometer at 562 nm. As a confirmatory step the number of live cells per well were counted under 10X objective, and 10X eyepiece magnification of compound microscope using Neubauer-improved counting chamber (Paul Marienfeld GmbH and Co. KG, Germany), cells were stained using trypan-blue.

Western blotting {#s4-5}
----------------

In general, wild type and knockout cells (treated and untreated) are harvested, washed with PBS for 2 times and lysed using Laemmli buffer, boiled and separated on SDS-PAGE and transferred to PVDF membrane, followed by probing with appropriate primary and secondary antibody. In the case of luciferase experiments, wild type and knockout cells were transfected with FlucDM-EGFP constructs and treated with different concentrations of H~2~O~2~. Following the treatment, these cells were lysed using NP-40 containing lysis buffer \[50 mM Tris--HCl (pH 7.8), 150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, 1 mM EDTA, protease inhibitor cocktail (Roche)\] and centrifuged at 12,000 g at 4°C for 15 min, the supernatant was used as the soluble fraction and the pellet was boiled in Laemmli buffer that was used as the insoluble fraction and was subjected to immunoblotting.

Sample preparation for mass spectrometry {#s4-6}
----------------------------------------

For purifying the reporter protein, GFP, the cells were transfected with pEGFP-N1 empty vector and allowed to grow for 24 hr, followed H~2~O~2~ treatment. Cells were initially washed with PBS and followed by lysis using a buffer containing 10 mM Tris (pH 7.8), 150 mM NaCl, 0.5 mM EDTA, 2 mM Na~3~VO~4~, 10 mM NaF, 10 mM N-ethylmaleimide, protease inhibitor mixture, and 0.5% Nonidet P-40. The lysates were subjected to centrifugation at 20,000 g, 10 min at 4°C, the supernatant was incubated with GFP-Trap beads (ChromoTek) for 2 hr at 4°C. The beads were washed with buffer containing ingredients of lysis buffer except for Nonidet P-40, to remove non-specifically bound proteins. To the GFP bound beads Laemmli sample buffer is added, boiled, and loaded on the SDS-PAGE. After running the PAGE gel followed by coomassie staining, regions containing the protein are sliced and subjected to reduction, alkylation, and in-gel digestion using Trypsin as described by [@bib76]. Finally, the peptides were desalted and enriched as per the protocol in [@bib64].

Mass spectrometry and analysis {#s4-7}
------------------------------

The Q Exactive HF (Thermo Fisher Scientiﬁc, Bremen, Germany) was used to perform HCD mode fragmentation and LC-MS/MS analysis. Samples were fractionated using commercial column PepMap RSLC C18, 3 μm, 100 Å, 75 μm i.d. ×150 mm. The LCs used were EASY-nLC 1200 systems (Thermo Fisher Scientiﬁc, San Jose, CA). The column temperature was maintained at 30°C. The peptides were loaded in solvent A (5% Acetonitrile 0.1% formic acid in Ultrapure water) and eluted with a nonlinear gradient of solvent B (0.1% TFA, 0.1% formic acid in 95% acetonitrile) by a gradient to 25% of solvent B over 35 min and 40% for 10 mins at a constant flow rate of 300 nL/min. Instruments were conﬁgured for DDA using the full MS/DD−MS/MS setup. Full MS resolutions were set to 60000 at m/z 200, and full MS AGC target was 3E6 with an IT of 100 ms. The mass range was set to 400--1650. AGC target value for fragment spectra was set at 1E5, and the intensity threshold was kept at 3E4. Isolation width was set at 1.3 m/z. The normalized collision energy was set at 28%. Peptide match was set to preferred, and isotope exclusion was on.

The data were analyzed in two software's PEAKS6.0. and Proteome Discoverer 2.2. Peaks 6.0 De novo sequencing and database search analysis parameters: Trypsin, and 3 allowed missed cleavages in one peptide end. The parent mass tolerance of 10 ppm using monoisotopic mass, and fragment ion tolerance of 0.05 Da. Carbamidomethylation of cysteine (+57.02) as a fixed modification, methionine oxidation (+15.99) and deamidation of asparagine and glutamine (NQ +0.98) were set as variable modifications. Data was validated using a false discovery rate (FDR) method. Peptide identifications were accepted for peptides with --10logP score cut-off was set to \>20 to achieve theoretical peptide FDR of 0.1%.

Proteome Discoverer is an MS data analysis platform provided by Thermo Fisher Scientiﬁc for its mass spectrometers. Raw files of GFP control and knockout samples were imported into Proteome Discoverer 2.2, and HTSequest algorithm search was used. In both the software, the sample was searched against the in-house mutant database. The enzyme specificity was set to trypsin, and three missed cleavages were allowed. Carbamidomethylation of cysteine was set as fixed modification and oxidation of methionine as a variable modification. The identified peptide sequence with more than threshold scores (--10logP score \>50 for peaks 6.0) were used to BLAST against wild type GFP protein sequence to find out mutations.

Sequence analysis and image generation {#s4-8}
--------------------------------------

All the sequences are extracted using the Protein-BLAST search and the structure-based sequence alignments are generated using the T-Coffee server ([@bib57]). Phylogenetic trees were constructed using iTOL server (<https://itol.embl.de/>). Images of different protein structures are generated using PyMOL. While the tRNA sequences are taken from GtRNAdb ([@bib11]).
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The results are interesting and significant in showing that threonyl-tRNA synthetase can edit misacylated Ala-tRNA^Thr^ in addition to Ser-tRNA^Thr^, and that this activity is inactivated by hydrogen peroxide; and in providing evidence that the parallel editing activity of Animalia-specific-tRNA Deacylase (ATD), which is insensitive to hydrogen peroxide, becomes important in cells treated with hydrogen peroxide for suppressing proteotoxic stress. It is also interesting that the appearance of ATD in evolution of Animalia appears to be coincident with that of tRNAs harboring the G4-U69 base pair that renders them prone to misacylation.

**Decision letter after peer review:**

Thank you for submitting your article \"Genomic innovation of ATD alleviates mistranslation associated with multicellularity in Animalia\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by James Manley as the Senior Editor The following individuals involved in review of your submission have agreed to reveal their identity: Michael Ibba (Reviewer \#2); Christopher Francklyn (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, we are asking editors to accept without delay manuscripts, like yours, that they judge can stand as *eLife* papers without additional data, even if they feel that they would make the manuscript stronger. Thus the revisions requested below only address clarity and presentation.

Summary:

It was known previously that ThrRS can edit misacylated Ser on tRNA^Thr^. This group previously showed that AlaRS can misacylate tRNA^Thr^ for tRNA^Thr^ isoacceptors containing a (G4-U69) pair in the acceptor stem, and that the enzyme ATD can deacylate Ala from such Ala-tRNA^Thr^ molecules. They hypothesized that ATD could serve a proofreading role in the cell. In this report, they show that ThrRS is also capable of deacylating Ala-tRNA^Thr^, apparently the first known case of one synthetase correcting the error made by another; and this activity is widespread among Animalia. They go on to show that this editing activity of ThrRS is inactivated in vitro by H~2~O~2~, whereas ATD\'s comparable activity is insensitive to H~2~O~2~, leading to the prediction that ATD should be critical for preventing Thr to Ala substitutions in proteins in cells undergoing oxidative stress. They test this by knocking out ATD with CRISPR and finding that this confers reduced cell viability on H~2~O~2~ treatment, which could be complemented by WT but not catalytically inactive ATD expression. They also observe increased Hsp70 expression in the ATD^-/-^ cells on H~2~O~2~ treatment, consistent with increased proteotoxic stress. Supporting this interpretation, they find increased aggregation of a specialized GFP reporter that serves as a reporter for mistranslation; and by mass-spec detected GFP peptides with Thr to Ala changes isolated from ATD^-/-^ mutant cells but not from WT cells. Finally, they present bioinformatics results indicating the appearance of ATD in the Choanoflagellates in parallel with the appearance of tRNAs containing the G-U pair in the acceptor stem that is expected to confer their misacylation with Ala by AlaRS and engender a requirement for ATD editing function. These evolutionary data support a role for ATD in editing Ala misacylation events.

Major revisions:

1\) Provide a modified Discussion that addresses (a) the fact that the effect of H~2~O~2~ on cells is not prolonged and so your results might apply only to acute oxidative stress; and also the relationship of H~2~O~2~-induced oxidative stress to the activation of NADPH oxidase; and (b) the rationale for use of Hsp70 induction as a marker for induction of the UPF in oxidative stress, noting the known ties between Hsp70 expression and impairment of the 26S proteosome, and with protein misfolding, particularly in neurodegenerative diseases. (R. Morimoto has reviewed this extensively).

2\) Comment on the observation that gamete producing cells (testis and ovaries) are the tissues where ATD is most highly expressed, which might be linked to tissue-specialized responses and sensitivity to oxidative stress.

3\) Make the appropriate revisions to respond to the other major points raised by the reviewers.

Reviewer \#1:

The results are interesting and significant in showing that ThrRS can edit Ala-tRNA^Thr^ errors in addition to Ser-tRNA^Thr^ errors, and that this activity is inactivated by H~2~O~2~; and in providing evidence that the parallel editing activity of ATD, which is insensitive to H~2~O~2~, becomes important in cells treated with H~2~O~2~ for suppressing proteotoxic stress. It is also interesting that the appearance of ATD in evolution of Animalia appears to be coincident with that of G4-U69 tRNAs.

Reviewer \#2:

In the present manuscript, the authors follow up on a previous report from their group (Kuncha et al., 2018.) in which they identified the Animalia-specific tRNA deacylase (ATD). They showed that ATD has enzymatic activity toward mis-aminoacylated Ala-tRNA^Thr^ substrates. Interestingly, the accumulation of this mis-aminoacylated tRNA species does not arise from errors in mis-activation of non-cognate substrates, but rather through mis-selection of the tRNA. Alanyl-tRNA synthetase (AlaRS) utilizes a G3-U70 base pair in the acceptor stem of tRNA^Ala^ for proper recognition. Previous efforts from this group and others have highlighted that in higher eukaryotes, many of the tRNA^Thr^ genes encode a G4-U69 base pair that can be mis-selected by eukaryotic AlaRS. While much of the previous work on ATD focused on the biophysical and biochemical interactions with its substrates, in this report, the authors sought to identify the role of ATD in vivo.

To characterize the function of ATD in vivo, the authors first generated an ATD knockout strain of HEK293T cells. The authors report that the ATD knockout alone caused no discernable phenotype and elicited no induction of the unfolded protein response (UPR) as determined by Western blotting of Hsp70. To ensure this was not due to an artifact in the specific cell type that was selected, the authors show that ATD is expressed across a wide array of tissue types in mice and expressed in various cell lines, which would presumably suggest that it likely is playing an important role in the cell.

As the ATD knockout line displayed no obvious cellular defects, the authors believed that another redundant proofreading factor may also act on Ala-tRNA^Thr^ substrates. One of the most interesting findings from this report was that threonyl-tRNA synthetase (ThrRS) has proofreading activity on Ala-tRNA^Thr^. It has been known for \~20 years that ThrRS utilizes post-transfer proofreading activity to correct mis-aminoacylated Ser-tRNA^Thr^, but the determination that ThrRS also has trans proofreading activity for a different aminoacyl-tRNA substrate was quite unexpected. This result suggests that both ThrRS and ATD can both act on mis-selected Ala-tRNA^Thr^.

It was previously shown that *E. coli* ThrRS is susceptible to oxidation at Cys182. This conserved cysteine is responsible for coordinating the 3\' end of the tRNA in the ThrRS proofreading domain, and upon oxidation, loses its deacylase activity for Ser-tRNA^Thr^. The authors then wanted to determine if ThrRS oxidation also perturbed Ala-tRNA^Thr^ deacylation. In fact, oxidative stress does cause an inactivation of ThrRS proofreading on the mis-alanylated tRNA species. This observation suggested that a primary role of ATD may be to deacylate this aminoacyl-tRNA during cellular oxidation.

The ATD knockout strains were revisited and treated with hydrogen peroxide to induce oxidative stress. Unlike the observations in Figure 1, upon oxidation, ATD is required to maintain cell viability and prevent the induction of the UPR. This model suggests that upon oxidation, ThrRS proofreading becomes inactivated thus making ATD the singular factor to deacylate Ala-tRNA^Thr^. To determine if the loss of ATD activity cause protein mistranslation and aggregation, the authors used both a GFP-based reporter and mass spectrometry to show that translational errors were occurring and disrupting proteostasis. An interesting secondary result from these experiments was that the authors could show that the predicted ablation of eukaryotic ThrRS proofreading during oxidative stress led to quantifiable changes in Thr to Ser protein mistranslation in eukaryotic cells. This observation correlates with previous studies in bacteria and will be an important result for those interested in studying mistranslation globally.

Having determined a role for ATD in higher eukaryotes, the authors sought to identify the ancestor for the evolutionary acquisition of ATD. As a model, the authors used the Choanoflagellate *Salpingoecarosetta*. *S. rosetta* is a unicellular organism but encodes for cell cycle and other factors reminiscent of higher eukaryotic physiology. *S. rosetta* ATD had deacylase activity on both Ala-tRNA^Thr^ and Ala-tRNA^Ala^ tRNAs suggesting this protein is more promiscuous for its substrates. This organism does not encode a G4-U69 containing tRNA^Thr^ gene but does however have a tRNA^Gln^ gene which does share this identity element. While not nearly as robust as the previous data, the authors provide some evidence that *S. rosetta* ATD may be important for preventing infrequent Ala-tRNA^Gln^ mis-aminoacylation events.

The aforementioned report is well written and provides new insight into the role of freestanding proofreading factors in higher eukaryotes. The authors utilized a combination of cellular and biochemical approaches to tell a convincing narrative which should allow for future investigation. Aside from a few comments listed below, I would recommend this manuscript for publication in *eLife*.

1\) The Western blots in Figure 1C/D and Figure 1---figure supplement 2 are somewhat difficult to interpret. While I agree that they do show the presence of ATD in all of the tissue/cell types, the loading controls are inconsistent. I am less concerned with the technical reproducibility of the sample loading across the different lanes, but more interested in the striking differences in ATD levels across those samples, especially if they were normalized to GAPDH. In those different tissue types, do you believe that GAPDH has varied expression, or do you think the differences in ATD correlate to a more important tissue-specific role of this factor? Furthermore, In Figure 1---figure supplement 2, the figure legend states that protein was normalized by \"ATD based normalization\" but it is not clear what that means as ATD levels in that blot also vary widely. This technical approach should be reworded for clarity. As a minor comment, the figure legend says that β-actin was used as a loading control, but the figure is labeled as GAPDH.

2\) Do the authors have any predicted regulatory mechanism for the elevated ATD levels shown in Figure 5C? Elaboration of this data would be an interesting discussion topic.

3\) In Figure 3---figure supplement 4, it is interesting that at position 162, there is variability at that residue with some organisms encoding phenylalanine and others with tyrosine. I am curious if you observed any differences in activity with organisms encoding one or the other amino acid? I am imagining a scenario in which encoding Phe could allow for potential modulation of activity during oxidative stress if that position is accessible and can be modified to tyrosine. Alternatively, oxidized Phe (i.e. tyrosine) may be a more active variant and could have become fixed in those species. It is difficult to interpret any differences in Figure 3---figure supplement 3, but I was wondering if you had observed any other differences between those enzymes? It may speak to an interesting co-regulation of elevated ATD activity during oxidation while ThrRS activity goes down. If you have any data to suggest that may be possible, it would be a very nice discussion point.

Reviewer \#3:

The central focus of this manuscript is the identification of conditions under which the Animalia specific tRNA deacylase (ATD) may be necessary for deacylation of tRNAs mis-activated with alanine. The evidence that ThrRS contains deacylation activity is solid, as is the evidence that ATD retains deacylation activity in the presence of H~2~O~2~ in vitro. The weakest part of the manuscript concerns the evidence that ATD and ThrRS functions as a de-acylase under oxidative stress conditions. The evidence that ATD reduces mistranslation is promising, but perhaps still a little preliminary. Overall, this manuscript provides additional characterization of the ATD enzyme, but lacks the decisive experiment that would signal a major advance in our understanding of mechanisms of protein quality control.

Specific comments and concerns:

1\) Concern: The lack of quantitation of specific activity of deacylase makes it difficult to assess the extent of the protective effect of ThrRS with regard to clearing Ala-tRNA^Thr^. The argument would be stronger if the authors were able to provide a quantitative comparison of deacylation rates, taking into account enzyme concentrations. This information is likely available from direct fitting of the progress curves that are provided, without performing new experiments.

2\) Comment: The retention of Ala-tRNA^Thr^ editing across all ThrRS is not that surprising, when you consider the specific contacts in the ThrRS editing site. While there are interactions that promote Ser-tRNA^Thr^ binding in the editing site, there is no chemical basis to discriminate against Ala in this pocket; hence, this activity is inherent in these enzymes. It also needs to be mentioned that, in prokaryotes, the levels of Ala-tRNA^Thr^ are likely to be significantly lower as a result of the G3:U70 identity element requirement for AlaRS in these taxa. Thus, there Ala-tRNA^Thr^ editing may have little biological impact in the parokaryotic context. The narrative could be modified to include a more nuanced discussion of this issue.

3\) Concern: A big concern I have is the use of H~2~O~2~ as a stimulant to induce oxidative stress. It is a good first step but shouldn\'t be the whole story. The problem is that H~2~O~2~ has a relatively short life when administered to cells, and the short-term physiological effects that it induces might not be reflective of longer-term adaptation. (inducers of the NADPH oxidase should be considered.) The data suggesting that ATD is essential during oxidative stress would have been more convincing if it were supported by independent measurements of oxidative stress in the cells. The β-mercaptoethanol experiments provide indirect support of the hypothesis at best. A difficulty here is that it is not easy to formally block deacylation activity of ThrRS without blocking aminoacylation. A Potential method to be considered involves use of redox sensitive dye molecules, which can provide quantitative information. The authors might also consider looking at conditions under which stress granules form, given the interest in mistranslation. This represents the only concern where additional experimental work might be warranted.

4\) Comment: While I would have liked to see a SILAC experiment formally comparing the extents of mistranslation ATD+ and ATD- cells, the mass spec data shown are promising and support the hypothesis that ATD forms this important editing function.

5\) Comment: I really like the bioinformatics section of the paper. This was a very thoughtful addition to the study, with nice broader biological implications. Going forward, it will be very interesting to investigate the evolutionary emergence of other components in the protein synthesis quality control apparatus. The approach here is readily adaptable to the analysis of other translation genes.

10.7554/eLife.58118.sa2

Author response

> Major revisions:
>
> 1\) Provide a modified Discussion that addresses (a) the fact that the effect of H~2~O~2~ on cells is not prolonged and so your results might apply only to acute oxidative stress; and also, the relationship of H~2~O~2~-induced oxidative stress to the activation of NADPH oxidase;

We agree with the reviewers that H~2~O~2~ induces acute oxidative stress, while NADPH oxidase is known to induce chronic oxidative stress. The toxicity experiments were done to bring out the role of ATD in the presence of oxidative stress. However, in the context of ATD, more targeted/focused studies to find out the subtle oxidative stress response using different NADPH oxidase activating molecules across different cell lines will be the focus of future studies. This is now included in the revised manuscript as: "The current work involves the use of acute oxidative stress (H~2~O~2~) and further prompts to look at the behaviour of ATD knockout cells in the presence of chronic oxidative stress such as activators of NADPH oxidase."

> b\) the rationale for use of Hsp70 induction as a marker for induction of the UPF in oxidative stress, noting the known ties between Hsp70 expression and impairment of the 26S proteosome, and with protein misfolding, particularly in neurodegenerative diseases. (R. Morimoto has reviewed this extensively).

We thank the reviewers for this suggestion. We have now included this in the revised manuscript as: "Hsp70 is a chaperone which is upregulated in response to protein misfolding and hence used as a marker to study proteostasis stress and is also implicated in aging and neurodegenerative diseases (Gupta et al., 2011; Hartl, 1996; Mosser et al., 2000; Rampelt et al., 2012; Sala et al., 2017)."

> 2\) Comment on the observation that gamete producing cells (testis and ovaries) are the tissues where ATD is most highly expressed, which might be linked to tissue-specialized responses and sensitivity to oxidative stress.

We have also noted the higher expression of ATD in reproductive organs and it is very likely due to the high oxidative stress in these tissues. This could be linked to the regulation of ATD levels under different conditions that need to be probed further. This aspect has been now included in the revised manuscript: "ATD expression levels are very likely modulated by the level of oxidative stress as seen in the case of reproductive tissues (Figure 1C, D), which also suggests a mode of regulation via feedback mechanism."

> 3\) Make the appropriate revisions to respond to the other major points raised by the reviewers.

We have now included all the revisions in the revised manuscript as mentioned below.

> Reviewer \#2:
>
> \[...\]
>
> 1\) The Western blots in Figures 1C/D and Figure 1---figure supplement 2 are somewhat difficult to interpret. While I agree that they do show the presence of ATD in all of the tissue/cell types, the loading controls are inconsistent. I am less concerned with the technical reproducibility of the sample loading across the different lanes, but more interested in the striking differences in ATD levels across those samples, especially if they were normalized to GAPDH. In those different tissue types, do you believe that GAPDH has varied expression, or do you think the differences in ATD correlate to a more important tissue-specific role of this factor? Furthermore, In Figure 1---figure supplement 2 , the figure legend states that protein was normalized by \"ATD based normalization\" but it is not clear what that means as ATD levels in that blot also vary widely. This technical approach should be reworded for clarity. As a minor comment, the figure legend says that β-actin was used as a loading control, but the figure is labeled as GAPDH.

Please also see the response to major revision 2, above. The house-keeping protein GAPDH is the most widely used loading control and is expected not to vary much among different tissues. Therefore, we agree with the reviewer that ATD expression is high in testis and ovaries hinting at a tissue-specific role, which is known to have high levels of oxidative stress, and the same is now included in the revised manuscript: "ATD expression levels are very likely modulated by the level of oxidative stress as seen in the case of reproductive tissues (Figure 1C, D), ...."

By stating ATD based normalization, we intended to say that due to high expression of ATD in a few cells/tissues we had to increase the overall protein load of samples in which ATD expression is low, this approach has allowed us to detect ATD in tissues expressing at very low levels. However, the usage of the word ATD-based normalization is not appropriate and hence this is now removed from the manuscript. We have also changed the figure legend of Figure 1---figure supplement 2 from β-actin to GAPDH and reworded as "...ATD protein was used as a positive control and GAPDH as a loading control." We are very thankful to the reviewer for these suggestions.

> 2\) Do the authors have any predicted regulatory mechanism for the elevated ATD levels shown in Figure 5C? Elaboration of this data would be an interesting discussion topic.

We acknowledge the reviewer for this pertinent suggestion. The increased expression of ATD upon H~2~O~2~ treatment, suggest a possible oxidative stress-induced positive feedback loop for the induction of ATD. This is now included in the discussion of the revised manuscript: "...which also suggests a mode of regulation via feedback mechanism."

> 3\) In Figure 3---figure supplement 4, it is interesting that at position 162, there is variability at that residue with some organisms encoding phenylalanine and others with tyrosine. I am curious if you observed any differences in activity with organisms encoding one or the other amino acid? I am imagining a scenario in which encoding Phe could allow for potential modulation of activity during oxidative stress if that position is accessible and can be modified to tyrosine. Alternatively, oxidized Phe (i.e. tyrosine) may be a more active variant and could have become fixed in those species. It is difficult to interpret any differences in Figure 3---figure supplement 3, but I was wondering if you had observed any other differences between those enzymes? It may speak to an interesting co-regulation of elevated ATD activity during oxidation while ThrRS activity goes down. If you have any data to suggest that may be possible, it would be a very nice discussion point.

As per the reviewer's suggestion, we have now analysed our data in the light of Phe oxidation as explained below. In the current study, we have biochemical data of ATD from multiple organisms (*H. sapiens*, *M. musculus*, *G. gallus*, *D. rerio*, and *H. vulgaris*). Of the five ATDs tested, Human ATD (HsATD) has a Phe, while all others harbour Tyr at this position (162 in MmATD). The biochemical data (Figure 3---figure supplement 3) does not show any notable difference in activity between the Y162 and F162 containing variants of ATD with and without H~2~O~2~. However, such a kind of regulation is very unlikely due to the lack of Phe invariance at this position ([Author response image 1](#sa2fig1){ref-type="fig"}).

![Conservation of Y162 of ATD.\
The image depicts the frequency plot of TNGPY/FTH motif generated using 200 sequences of ATD.](elife-58118-resp-fig1){#sa2fig1}

> Reviewer \#3:
>
> \[...\]
>
> Specific comments and concerns:
>
> 1\) Concern: The lack of quantitation of specific activity of deacylase makes it difficult to assess the extent of the protective effect of ThrRS with regard to clearing Ala-tRNA^Thr^. The argument would be stronger if the authors were able to provide a quantitative comparison of deacylation rates, taking into account enzyme concentrations. This information is likely available from direct fitting of the progress curves that are provided, without performing new experiments.

As correctly suggested by the reviewer, we have now calculated the rates of deacylation, and included them as a table in the revised manuscript.

> 2\) Comment: the retention of Ala-tRNA^Thr^ editing across all ThrRS is not that surprising, when you consider the specific contacts in the ThrRS editing site. While there are interactions that promote Ser-tRNA^Thr^ binding in the editing site, there is no chemical basis to discriminate against Ala in this pocket; hence, this activity is inherent in these enzymes. It also needs to be mentioned that, in prokaryotes, the levels of Ala-tRNA^Thr^ are likely to be significantly lower as a result of the G3:U70 identity element requirement for AlaRS in these taxa. Thus, there Ala-tRNA^Thr^ editing may have little biological impact in the parokaryotic context. The narrative could be modified to include a more nuanced discussion of this issue.

As correctly pointed out by the reviewer, the bacterial AlaRS is not ambiguous in tRNA selection and therefore charges only tRNAs harbouring G3-U70, but not G4-U69. Since G3-U70 is very specific to tRNA^Ala^, the problem of tRNA mis-selection does not exist in prokaryotes and therefore ATD is absent in these organisms. This is now more elaborately mentioned in the revised manuscript: "...even though neither Bacteria (bacterial AlaRS is discriminatory and charges only tRNAs containing G3-U70 (Sun et al., 2016)) nor lower eukaryotes (which lack tRNAs containing G4-U69) possess the problem of tRNA mis-selection."

> 3\) Concern: A big concern I have is the use of H~2~O~2~ as a stimulant to induce oxidative stress. It is a good first step but shouldn\'t be the whole story. The problem is that H~2~O~2~ has a relatively short life when administered to cells, and the short-term physiological effects that it induces might not be reflective of longer-term adaptation. (inducers of the NADPH oxidase should be considered.) The data suggesting that ATD is essential during oxidative stress would have been more convincing if it were supported by independent measurements of oxidative stress in the cells. The β-mercaptoethanol experiments provide indirect support of the hypothesis at best. A difficulty here is that it is not easy to formally block deacylation activity of ThrRS without blocking aminoacylation. A Potential method to be considered involves use of redox sensitive dye molecules, which can provide quantitative information. The authors might also consider looking at conditions under which stress granules form, given the interest in mistranslation. This represents the only concern where additional experimental work might be warranted.

We thank the reviewer for bringing up this point. As a first major study, we have used H~2~O~2~ to bring out the role of ATD in the presence of acute oxidative stress as has been followed generally by others in the field. As correctly stated by the reviewer, the H~2~O~2~ toxicity experiments are further supported by the toxicity caused due to depletion of reducing agent (β-mercaptoethanol) in mouse ES cells. However, intricate studies would be required in the future to look at the subtle effect of oxidative stress on ATD knockout cells in the presence of NADH oxidase activators in combination with assessing the cellular ROS (using redox dyes). We thank the reviewer for the suggestion of using FlucDM, the sensor of proteome stress, as a screen for testing different conditions in which ATD plays an essential role in maintaining proteome homeostasis, which we intend to use in our future studies. Based on the reviewer's comments we have now included these aspects in our revised manuscript.

> 4\) Comment: While I would have liked to see a SILAC experiment formally comparing the extents of mistranslation ATD+ and ATD- cells, the mass spec data shown are promising and support the hypothesis that ATD forms this important editing function.

We agree with the reviewer and this will be our future course of study in different cell lines using different ROS inducers to precisely quantify the extent of mistranslation.

> 5\) Comment: I really like the bioinformatics section of the paper. This was a very thoughtful addition to the study, with nice broader biological implications. Going forward, it will be very interesting to investigate the evolutionary emergence of other components in the protein synthesis quality control apparatus. The approach here is readily adaptable to the analysis of other translation genes.

We thank the reviewer for this comment.
